EULAR 2026… EULAR 2026 Highlights – SLE and APS 24 Jul 2026 Belimumab step-down dose spacing in patients with systemic lupus erythematosus in persistent clinical remission: experience from a multicentre cohort Abstract format and assignment number: Poster presentation, POS1052 Presenting author: A.…
EULAR 2025 highlights… EULAR 2025 Highlights – SLE and APS 18 Jul 2025 Preliminary results of CD19/BCMA Dual-Targeting FasTCAR-T Cells GC012F (AZD0120) in patients with refractory Systemic Lupus Erythematosus-an open-label, single-arm study Abstract format and assignment number: Oral presentation OP0074 Date: Wednesday, 11…
Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) [ACR22] Systemic Lupus Erythmatosus and Antiphospholipid Syndrome 29 Nov 20226 Dec 2022 Author: Cristiana Sieiro Santos Luong et al. (0320) described the use of metabolomic analysis of metabolites to identify biomarkers of disease activity or adverse pregnancy outcomes (APO) in SLE. Low-density…